OrbiMed Israel BioFund GP Limited Partnership

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$284,439.00
Insider Sells Quantity
1
Insider Sells Sum
$9,279.93

Insider Activity of OrbiMed Israel BioFund GP Limited Partnership

According to the SEC Form 4 filings, OrbiMed Israel BioFund GP Limited Partnership, being in a position of

  1. 10 percent owner at BiomX Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24344 shares for $9,280,
    over all time since 2019-12-05, has bought 375327 shares for $284,439, and sold 24344 shares for $9,280.

The largest purchase of all time was on 2023-02-27 and amounted to 348000 shares of BiomX Inc. for $85,260.

The largest sale of all time was on 2024-05-15 and amounted to 24344 shares of BiomX Inc. for $9,280.

Biography of OrbiMed Israel BioFund GP Limited Partnership

No biography is available at this moment.

2024-05-15SaleBiomX Inc.
PHGE
10 percent owner
24,344
0.0486%
$0.38$9,280-45.38%
2024-03-15PurchaseBiomX Inc.
PHGE
10 percent owner
4,327
$0$0-10.52%
2023-02-27PurchaseBiomX Inc.
PHGE
10 percent owner
348,000
0.7935%
$0.24$85,260-12.5%
2019-12-19PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,500
0.0555%
$8.90$31,150-39%
2019-12-18PurchaseBiomX Inc.
PHGE
director, 10 percent owner
500
0.0089%
$8.93$4,465-31.69%
2019-12-11PurchaseBiomX Inc.
PHGE
director, 10 percent owner
5,400
0.0956%
$8.92$48,168-31.77%
2019-12-10PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,400
0.0603%
$8.75$29,750-30.3%
2019-12-09PurchaseBiomX Inc.
PHGE
director, 10 percent owner
6,000
0.1072%
$8.68$52,080-29.25%
2019-12-06PurchaseBiomX Inc.
PHGE
director, 10 percent owner
800
0.0134%
$8.00$6,400-27.92%
2019-12-05PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,400
0.0605%
$7.99$27,166-23.38%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.